Mass Spectrometry Market | Growth, Trends, and Forecast (2019-2024)

Market Snapshot

Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

7.27%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The mass spectrometry market is expected witness a CAGR of 7.27% during the forecast period. Certain factors that are driving the market growth include the increasing technological advancement, growing concerns over food safety, and rising R&D expenditure by the pharmaceutical industry and government research organizations.

Mass spectrometry (MS) is one of the most powerful tools used for the analyses of a wide range of chemical and biological entities. In addition, the high demand and resulting requirements from the pharmaceutical and biotechnology industries are the main driving factors for some extraordinary recent advances in mass spectrometry technology. The advancements in mass spectroscopy technology were able to increase the factors like rapid test results with high resolution. The discovery of new tools and software has the potential to stimulate the usage of mass spectroscopy across drugs development, proteomics, pharmaceuticals, food safety testing, and many other fields. The demands of the life sciences applications have led to the improvement of MS technologies and the rapid growth of new types of instruments. New mass spectrometry methods, collectively known as data independent analysis and hyper reaction monitoring, have recently emerged. Understanding complexity related to cancer biology requires extensive information about the cancer proteome over the course of the disease. Hence, with the increasing technological advancement, the market is expected to grow.

Scope of the Report

As per the scope of this report, mass spectrometry (MS) is an analytical chemistry technique used to identify the amount and type of chemical species present in a sample, by measuring the mass-to-charge ratio and abundance of gas phase ions.

Technology

Hybrid Mass Spectrometry
	Triple Quadrupole (Tandem)
	Quadrupole TOF (Q-TOF)
	FTMS (Fourier Transform Mass Spectrometry)

Single Mass Spectrometry
	ION Trap
	Quadrupole
	Time-of-Flight (TOF)

Other Mass Spectrometry

Application
		Pharmaceuticals Industry
		Biotechnology Industry
		Chemical Industry
		Environmental Testing
		Food and Beverage Testing
		Other Applications

Geography

North America
	US
	Canada
	Mexico

Europe
	Germany
	UK
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Triple Quadrupole (Tandem) is Expected to Hold Significant Market Share in the Type of Hybrid Mass Spectrometry

Tandem mass spectrometry devices are currently among the most in demand. Conventional hospital diagnostic assays are based on clinical chemistry and immunoassay techniques that require analyte specific reagents and antibodies. LC-MS/MS-based approaches are considered reagent-free. The high specificity and sensitivity of LC-MS/MS overcome many limitations associated with the traditional immunoassays, such as non-specific antibody binding and cross-reactivity. There is a higher demand for hybrid instruments, such as triple quadrupole mass spectrometer, quadrupole time-of-flight mass spectrometer, etc. Currently, triple quadrupole MS is considered one of the most high-end instruments and many labs across the world are adopting this instrument.

To understand key trends, Download Sample Report

North America Dominates the Market and Expected to do the Same in the Forecast Period

According to the Industrial Research Institute (IRI) report, the United States spends the world’s highest (i.e., USD 516 billion) amount for research and development, currently. The United States spends 43% of the total life sciences/healthcare research and development and 56% of pharmaceutical/biotech R&D spending worldwide. Research and development include drug development and fundamental science research. Drug development, from the initial discovery to the final medication, is an expensive and lengthy process, and the failure rate is also high. High cost, lengthy time period, and the high failure rate are forcing researchers and drug manufacturing companies to look for newer technology, which can improve the process and reduce the cost at the same time. Mass spectrometry has the potential to do the same. It makes a functional and structural study, which takes a significant amount of time and resource in drug development, for the molecule, easier and faster.

To understand geography trends, Download Sample Report

Competitive Landscape

The mass spectrometry market is highly competitive and consists of a few major players. Companies like Agilent Technologies, Bruker Corporation, Danaher Corporation, Dani instruments s.p.a, Leco Corporation, Perkin Elmer Inc., Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation, among others, hold the substantial market share in the mass spectrometry market.

Major Players

* Complete list of players covered available in the table of contents below

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Increasing Technological Advancement
  2. 4.2.2 Growing Concerns Over Food Safety
  3. 4.2.3 Rising R&D Expenditure By Pharmaceutical Industry & Government Research Organizations
3. 4.3 Market Restraints
  1. 4.3.1 High Cost Of Instrument
  2. 4.3.2 Lack Of Skilled Technicians
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 Technology
  1. 5.1.1 Hybrid Mass Spectrometry
    1. 5.1.1.1 Triple Quadrupole (Tandem)
    2. 5.1.1.2 Quadrupole TOF (Q-TOF)
    3. 5.1.1.3 FTMS (Fourier Transform Mass Spectrometry)
  2. 5.1.2 Single Mass Spectrometry
    1. 5.1.2.1 ION Trap
    2. 5.1.2.2 Quadrupole
    3. 5.1.2.3 Time-of-Flight (TOF)
  3. 5.1.3 Other Mass Spectrometry
2. 5.2 Application
  1. 5.2.1 Pharmaceuticals Industry
  2. 5.2.2 Biotechnology Industry
  3. 5.2.3 Chemical Industry
  4. 5.2.4 Environmental Testing
  5. 5.2.5 Food and Beverage Testing
  6. 5.2.6 Other Applications
3. 5.3 Geography
  1. 5.3.1 North America
    1. 5.3.1.1 US
    2. 5.3.1.2 Canada
    3. 5.3.1.3 Mexico
  2. 5.3.2 Europe
    1. 5.3.2.1 Germany
    2. 5.3.2.2 UK
    3. 5.3.2.3 France
    4. 5.3.2.4 Italy
    5. 5.3.2.5 Spain
    6. 5.3.2.6 Rest of Europe
  3. 5.3.3 Asia-Pacific
    1. 5.3.3.1 China
    2. 5.3.3.2 Japan
    3. 5.3.3.3 India
    4. 5.3.3.4 Australia
    5. 5.3.3.5 South Korea
    6. 5.3.3.6 Rest of Asia-Pacific
  4. 5.3.4 Middle East & Africa
    1. 5.3.4.1 GCC
    2. 5.3.4.2 South Africa
    3. 5.3.4.3 Rest of Middle East & Africa
  5. 5.3.5 South America
    1. 5.3.5.1 Brazil
    2. 5.3.5.2 Argentina
    3. 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Agilent Technologies
  2. 6.1.2 Bruker Corporation
  3. 6.1.3 Danaher Corporation
  4. 6.1.4 Dani Instruments
  5. 6.1.5 Leco Corporation
  6. 6.1.6 Perkin elmer Inc.
  7. 6.1.7 Shimadzu Corporation
  8. 6.1.8 Thermo Fisher Scientific
  9. 6.1.9 Waters Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments